MedTrace Logo

Evaluation of Different Treatment Modalities for Lower Pole and Renal Pelvis Stones

NCT02522676 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2019-11-19

No results posted yet for this study

Summary

It is aimed to evaluate the treatment results, rates of success and complications, and injury given to the kidney by measuring preoperative and postoperative blood urea, creatinine, Cystatin C and Netrin-1 levels and urine Cystatin C and Netrin-1 levels in patients with lower pole or renal pelvis stone(s) undergoing either one of the treatment modalities including conventional percutaneous nephrolithotripsy (PCNL), mini PCNL, ultra-mini PCNL, micro PCNL, retrograde intrarenal surgery (RIRS) and extracorporeal shock wave lithotripsy (ESWL).

Conditions

  • Kidney Stones

Interventions

PROCEDURE

Endoscopic kidney stone surgery

Conventional PCNL will be performed.

PROCEDURE

Endoscopic kidney stone surgery

Mini PCNL will be performed.

PROCEDURE

Endoscopic kidney stone surgery

Ultra-mini PCNL will be performed.

PROCEDURE

Endoscopic kidney stone surgery

Micro PCNL will be performed.

PROCEDURE

Endoscopic kidney stone surgery

Retrograde intrarenal surgery will be performed.

PROCEDURE

Non-invasive kidney stone treatment

Extracorporeal shock wave will be performed.

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER

  • Selcuk University

    lead OTHER

Principal Investigators

  • Murat Akand, M.D. · Selcuk University, School of Medicine, Department of Urology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2023-06-30
Completion
2023-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02522676 on ClinicalTrials.gov